Receive real-time job alerts and never miss the right job again
US - PA - Philadelphia
July 24, 2024
Philadelphia, PA • Cabaletta Bio (Nasdaq: • CABA) is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies that have the potential to provide a deep and durable, perhaps curative, treatment for patients with autoimmune diseases. • The CABA™...
US - PA - Phila
August 3, 2024
Philadelphia, PA • Cabaletta Bio (Nasdaq: • CABA) is a clinical-stage biotechnology company focused on developing and launching targeted, potentially curative, cellular therapies for patients with autoimmune diseases. • The CABA platform includes two strategies to treat and...